CRDF SEC Filings - Cardiff Oncology Inc 10-K, 10-Q, 8-K Forms

This page provides a comprehensive resource for Cardiff Oncology Inc. (CRDF) SEC filings, including 10-K, 10-Q, and 8-K forms, as well as insider trading reports. It highlights recent filings such as a Form 4 regarding stock options for Director Gary W. Pace and an 8-K detailing the annual meeting results, including director elections and an expansion of the stock incentive plan. The platform also offers AI-powered summaries, impact scoring, and sentiment analysis for each filing.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin